The effect of Atorvastatin and rosuvastatin on the Levels of 25 Hydroxyvitamin D
Phase 4
- Conditions
- Patient with Acute Coronary Syndrome.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
- Registration Number
- IRCT20190902044673N1
- Lead Sponsor
- eyshabour University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Acute Coronary Syndrome with: chest pain, ECG ST elevation and Troponin Enzyme rising
Exclusion Criteria
Diabetes Mellitus
Take anti-lipid drugs during three past months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 25-hydroxy vitamin D level. Timepoint: At the beginning ,the first 24 hours of hospitalization, two months after admission. Method of measurement: 25-hydroxy vitamin D level in blood.
- Secondary Outcome Measures
Name Time Method